These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 19524652)

  • 1. CDs as solubilizers: effects of excipients and competing drugs.
    Jansook P; Loftsson T
    Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P; Pichayakorn W; Muankaew C; Loftsson T
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gammaCD/HPgammaCD: synergistic solubilization.
    Jansook P; Loftsson T
    Int J Pharm; 2008 Nov; 363(1-2):217-9. PubMed ID: 18691643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
    Thompson DO
    Crit Rev Ther Drug Carrier Syst; 1997; 14(1):1-104. PubMed ID: 9043816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
    J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.
    Brewster ME; Loftsson T
    Pharmazie; 2002 Feb; 57(2):94-101. PubMed ID: 11878196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The self-assemble of natural cyclodextrins in aqueous solutions: Application of miniature permeation studies for critical aggregation concentration (cac) determinations.
    Saokham P; Sá Couto A; Ryzhakov A; Loftsson T
    Int J Pharm; 2016 May; 505(1-2):187-93. PubMed ID: 27021466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
    Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
    Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients.
    Muankaew C; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2014 Oct; 474(1-2):80-90. PubMed ID: 25128698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
    Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
    J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
    Ueda H; Ou D; Endo T; Nagase H; Tomono K; Nagai T
    Drug Dev Ind Pharm; 1998 Sep; 24(9):863-7. PubMed ID: 9876538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrins as pharmaceutical solubilizers.
    Brewster ME; Loftsson T
    Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.